Apatinib (YN968D1): Mechanism of Action

Apatinib (YN968D1) MOA:Targeting VEGFR-2/VEGF Signaling Pathway for Gastric Cancer

🎯 check Apatinib (YN968D1) product page

Apatinib (YN968D1) is a potent, highly selective, ATP-competitive VEGFR2 inhibitor. It affects VEGF/VEGFR signaling by binding to the intracellular ATP-binding site to prevent receptor phosphorylation, effectively inhibiting tumor angiogenesis and endothelial cell proliferation.

Primary Applications and Mechanism of Action